HK Stock Market Move | The Hong Kong Stock Exchange (00388) rose nearly 2% in the afternoon, with a 24% year-on-year increase in net profit for the first half of the year, reaching a record high for any half-year period.
The Hong Kong Stock Exchange (00388) rose nearly 2% in the afternoon. As of the time of this report, it was up 1.73%, trading at HKD 412, with a transaction volume of HKD 941 million.
Hong Kong Exchanges and Clearing (00388) rose nearly 2% in the afternoon, and as of the time of writing, it was up 1.73% at HK$412, with a trading volume of HK$941 million.
On the news front, HKEX released its mid-year results for 2026, with both revenue and profit hitting record highs for a half-year period, surpassing the previous record set in the second half of 2025. Specifically, for the first half of the year, revenue and other income totaled HK$16.702 billion, representing a year-on-year increase of 19%; attributable profit to shareholders was HK$10.568 billion, up 24% year-on-year; and it proposed an interim dividend of HK$7.43 per share. Second-quarter revenue and other income amounted to HK$8.499 billion, an 18% year-on-year increase; attributable profit to shareholders was HK$5.38 billion, up 21% year-on-year.
Goldman Sachs released a research report stating that it expects HKEX's stock price to respond positively to its second-quarter results. The second-quarter net profit was HK$5.4 billion, a year-on-year increase of 21% and a sequential increase of 4%, which exceeded the bank's and the market's expectations by 11% and 15%, respectively. Revenue (excluding investment income) was 5% higher than the bank's expectations, and investment income was also above expectations, driven by fair value gains from investments in unlisted companies. The rating is "Buy," with a target price of HK$540.
Related Articles

Shinva Medical Instrument (600587.SH): "Single-use plasma surgical electrode" has obtained Class III medical device registration certificate.

HK Stock Market Move | CITYCHAMP (00256) surged over 3% in the afternoon trading, expecting that the shareholder profit attributable to shareholders in the first half of the year will not be less than HKD 40 million.

SK Hynix (SKHY.US) has announced a significant shareholder return plan! It intends to repurchase and cancel stocks worth 40 trillion Korean won, with over 50% of the accumulated free cash flow to be returned.
Shinva Medical Instrument (600587.SH): "Single-use plasma surgical electrode" has obtained Class III medical device registration certificate.

HK Stock Market Move | CITYCHAMP (00256) surged over 3% in the afternoon trading, expecting that the shareholder profit attributable to shareholders in the first half of the year will not be less than HKD 40 million.

SK Hynix (SKHY.US) has announced a significant shareholder return plan! It intends to repurchase and cancel stocks worth 40 trillion Korean won, with over 50% of the accumulated free cash flow to be returned.

RECOMMEND





